Tolebrutinib New
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 1971920-73-6 | Cat. No. | BCP33289 |
| Name | Tolebrutinib | ||
| Synonyms | SAR442168; SAR-442168; SAR 442168; | ||
| SMILES | C=CC(=O)N1CCCC(C1)N2C3=C(C(=NC=C3)N)N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5 | ||
| Chemical Name | |||
| Formula | C26H25N5O3 | M. Wt | 455.51 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Tolebrutinib is an orally bioavailable, brain-penetrant, selective, small molecule inhibitor of Bruton's tyrosine kinase (BTK), with potential immunomodulatory and anti-inflammatory activities. Upon oral administration, tolebrutinib is able to cross the blood-brain barrier and inhibits the activity of BTK both peripherally and in the central nervous system (CNS). This prevents the activation of the B-cell antigen receptor (BCR) signaling pathway, and the resulting immune activation and inflammation. The inhibition of BTK activity also prevents microglial inflammatory signaling in the CNS, and the resulting immune activation, neuroinflammation and neurodegeneration. BTK, a cytoplasmic tyrosine kinase and member of the Tec family of kinases, plays an important role in B lymphocyte development, activation, signaling, proliferation and survival. In addition to B cells, BTK is also expressed in innate immune cells, including macrophages and microglia, and plays an important role in the regulation of microglial inflammatory signaling. | ||
Recommend Products
More >
-
Sunvozertinib
Cat. No.：BCP46584
No.：2370013-12-8
Product Details -
-
-
-
Rilzabrutinib
Cat. No.：BCP43077
No.：1575596-29-0
Product Details -
Pirtobrutinib
Cat. No.：BCP42730
No.：2101700-15-4
Product Details -
-
Olmutinib dihydrochloride
Cat. No.：BCP38296
No.：1842366-97-5
Product Details -
Orelabrutinib
Cat. No.：BCP37603
No.：1655504-04-3
Product Details -
Remibrutinib
Cat. No.：BCP36887
No.：1787294-07-8
Product Details -
-
-
Btk inhibitor 1 R enantiomer hydrochloride
Cat. No.：BCP30305
No.：1553977-42-6
Product Details -
-
(R)-Zanubrutinib
Cat. No.：BCP30082
No.：1691249-44-1
Product Details -
Vecabrutinib
Cat. No.：BCP29646
No.：1510829-06-7
Product Details -
BMS-986142
Cat. No.：BCP29622
No.：1643368-58-4
Product Details -
BMS-986195
Cat. No.：BCP29496
No.：1912445-55-6
Product Details -
Zanubrutinib
Cat. No.：BCP29110
No.：1691249-45-2
Product Details -
Ibrutinib Racemate
Cat. No.：BCP24087
No.：936563-87-0
Product Details
Tags:Tolebrutinib supplier,Tolebrutinib purchase,Tolebrutinib manufacturer,Tolebrutinib distributor,Tolebrutinib cost,Tolebrutinib buy,Tolebrutinib for sale